SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-09-012950
Filing Date
2009-05-20
Accepted
2009-05-20 16:51:52
Documents
9
Period of Report
2009-05-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 REXAHN PHARMACEUTICAL INC 8-K 5-19-2009 form8-k.htm 8-K 41036
2 EXHIBIT 1.1 ex1_1.htm EX-1.1 158778
3 EXHIBIT 1.2 ex1_2.htm EX-1.2 17245
4 EXHIBIT 4.1 ex4_1.htm EX-4.1 110266
5 EXHIBIT 5.1 ex5_1.htm EX-5.1 14048
6 EXHIBIT 10.1 ex10_1.htm EX-10.1 210306
7 EXHIBIT 99.1 ex99_1.htm EX-99.1 10966
8 LOGO logo.jpg GRAPHIC 5996
9 LOGO logo2.jpg GRAPHIC 2396
  Complete submission text file 0001140361-09-012950.txt   576089
Mailing Address 9620 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 2402685300
REXAHN PHARMACEUTICALS, INC. (Filer) CIK: 0001228627 (see all company filings)

IRS No.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34079 | Film No.: 09843124
SIC: 2834 Pharmaceutical Preparations